 |
MorphoSys AG
MOR
|
1.75 |
- |
2.43 % |
$ 254 M |
Germany |
 |
AbCellera Biologics
ABCL
|
12.8 |
$ 3.44 |
-4.32 % |
$ 1.03 B |
Canada |
 |
Acorda Therapeutics
ACOR
|
0.142 |
- |
-24.86 % |
$ 820 K |
USA |
 |
I-Mab
IMAB
|
94.1 |
- |
- |
$ 866 M |
China |
 |
Acer Therapeutics
ACER
|
25.8 |
- |
2.71 % |
$ 14 M |
USA |
 |
Alexion Pharmaceuticals, Inc.
ALXN
|
5.53 |
- |
- |
$ 40.3 B |
USA |
 |
ADMA Biologics
ADMA
|
7.41 |
$ 15.36 |
-2.17 % |
$ 3.66 B |
USA |
 |
Cellectis S.A.
CLLS
|
6.69 |
$ 3.53 |
-3.54 % |
$ 116 M |
France |
 |
AgeX Therapeutics
AGE
|
0.099 |
- |
-10.17 % |
$ 12.2 K |
USA |
 |
Apellis Pharmaceuticals
APLS
|
2.76 |
$ 20.28 |
0.65 % |
$ 2.56 B |
USA |
 |
Aeglea BioTherapeutics
AGLE
|
489 |
- |
- |
$ 1.01 B |
USA |
 |
Applied Genetic Technologies Corporation
AGTC
|
65.5 |
- |
- |
$ 26.5 M |
USA |
 |
EyeGate Pharmaceuticals, Inc.
EYEG
|
2.39 K |
- |
-1.52 % |
$ 24.7 M |
USA |
 |
Midatech Pharma plc
MTP
|
137 |
- |
-18.52 % |
$ 27.3 M |
Britain |
 |
Alpine Immune Sciences
ALPN
|
8.94 |
- |
- |
$ 2.17 B |
USA |
 |
Nymox Pharmaceutical Corporation
NYMX
|
38.5 K |
- |
-19.68 % |
$ 18.4 M |
Canada |
 |
Aptorum Group Limited
APM
|
105 |
$ 0.79 |
-1.15 % |
$ 4.31 M |
China |
 |
Autolus Therapeutics plc
AUTL
|
1.37 K |
$ 1.51 |
1.35 % |
$ 385 M |
Britain |
 |
China SXT Pharmaceuticals
SXTC
|
0.0979 |
$ 2.01 |
-1.36 % |
$ 2.86 M |
China |
 |
Galmed Pharmaceuticals Ltd.
GLMD
|
73.3 |
$ 0.67 |
7.08 % |
$ 624 K |
Israel |
 |
Adverum Biotechnologies
ADVM
|
76.4 |
- |
- |
$ 86.2 M |
USA |
 |
Ampio Pharmaceuticals
AMPE
|
106 |
- |
-11.43 % |
$ 502 K |
USA |
 |
Институт стволовых клеток человека
ISKJ
|
2.61 |
- |
- |
- |
Russia |
 |
Anika Therapeutics
ANIK
|
2.24 |
$ 14.05 |
-1.44 % |
$ 206 M |
USA |
 |
ANI Pharmaceuticals
ANIP
|
1.95 |
$ 74.36 |
-1.64 % |
$ 1.44 B |
USA |
 |
Applied Therapeutics
APLT
|
54.1 |
- |
- |
$ 8.42 M |
USA |
 |
Aravive
ARAV
|
6.61 |
- |
-13.39 % |
$ 1.45 M |
USA |
 |
Athersys
ATHX
|
253 |
- |
3.77 % |
$ 22.4 M |
USA |
 |
AVEO Pharmaceuticals
AVEO
|
2.32 |
- |
- |
$ 521 M |
USA |
 |
Axsome Therapeutics
AXSM
|
13.6 |
$ 162.43 |
0.6 % |
$ 8.08 B |
USA |
 |
BioCryst Pharmaceuticals
BCRX
|
3.81 |
$ 8.49 |
-0.18 % |
$ 1.75 B |
USA |
 |
BridgeBio Pharma
BBIO
|
26.1 |
$ 65.66 |
-0.78 % |
$ 12.6 B |
USA |
 |
Acasti Pharma
ACST
|
0.203 |
- |
4.01 % |
$ 150 M |
Canada |
 |
BioDelivery Sciences International
BDSI
|
1.85 |
- |
-4.8 % |
$ 255 M |
USA |
 |
BeiGene, Ltd.
BGNE
|
66.4 |
- |
0.49 % |
$ 251 B |
Cayman-islands |
 |
Bellicum Pharmaceuticals
BLCM
|
5.55 |
- |
-9.72 % |
$ 5.89 M |
USA |
 |
Berkeley Lights
BLI
|
1.49 |
- |
-7.31 % |
$ 87 M |
USA |
 |
CureVac N.V.
CVAC
|
281 |
- |
- |
$ 867 M |
Germany |
 |
Aeterna Zentaris
AEZS
|
7.87 |
- |
5.93 % |
$ 314 M |
Canada |
 |
BioMarin Pharmaceutical
BMRN
|
3.63 |
$ 61.3 |
1.21 % |
$ 11.8 B |
USA |
 |
Burford Capital Limited
BUR
|
6.35 |
$ 7.79 |
-5.75 % |
$ 1.28 B |
Britain |
 |
CymaBay Therapeutics
CBAY
|
110 |
- |
- |
$ 3.45 B |
USA |